MPX

Pixelgen Technologies Announces Peer-Review Publication on Molecular Pixelation Technology in Nature Methods

Retrieved on: 
Wednesday, May 8, 2024
Royal Society Te Apārangi, Karolinska Institute, Cancer, Protein, MPX, Cell, Pixelation, Proteomics, MD, AOCS, Doctor of Philosophy, Research, Imperial College London, DNA, PBMC, Light, Spatial analysis, Microscopy, Messenger, Paper, B cell, Immobilization, NK, Royal institute, Monocyte, Flow cytometry, Vaccine

STOCKHOLM, May 8, 2024 /PRNewswire/ -- Pixelgen Technologies, a leader in spatial proteomics for single cells, announced today that researchers from Pixelgen, the Karolinska Institute, Imperial College of London, and the Royal Institute of Technology in Sweden have demonstrated a ground-breaking sequencing-based method for identifying the relative locations of highly-multiplexed immunologically relevant proteins in single cells, in a peer-reviewed article published in Nature Methods. The Molecular Pixelation (MPX) technology used in the study is the first to demonstrate spatial proteomics of single cells without light, enabling multiplexing, throughput, and spatial resolution in 3D for proteomics-level single cell research.

Key Points: 
  • The Molecular Pixelation (MPX) technology used in the study is the first to demonstrate spatial proteomics of single cells without light, enabling multiplexing, throughput, and spatial resolution in 3D for proteomics-level single cell research.
  • The study, titled "Molecular Pixelation: Spatial Proteomics of single cells by sequencing," illustrates the ability of a DNA-barcode-based strategy to identify and visualize in 3D the spatial protein organization of immune cell receptors.
  • How immune cell surface receptors are organized relative to each other, and their behavior control many of a cell's vital functions.
  • Researchers have traditionally studied spatial surface protein organization with microscopy, using fluorophore-labeled antibodies on immobilized samples or with flow cytometry.

Marine Products Corporation Announces Date for First Quarter 2024 Financial Results and Conference Call

Retrieved on: 
Thursday, April 4, 2024
Interest, Telephone, MPX, Chaparral, Common snook, SURF

ATLANTA, April 4, 2024 /PRNewswire/ -- Marine Products Corporation (NYSE: MPX) announced today that it will release its financial results for the first quarter ended March 31, 2024 on Thursday, April 25, 2024 before the market opens.  In conjunction with its earnings release, the Company will host a conference call to review the Company's financial and operating results on Thursday, April 25, 2024 at 8:00 a.m. Eastern Time.

Key Points: 
  • ATLANTA, April 4, 2024 /PRNewswire/ -- Marine Products Corporation (NYSE: MPX) announced today that it will release its financial results for the first quarter ended March 31, 2024 on Thursday, April 25, 2024 before the market opens.
  • In conjunction with its earnings release, the Company will host a conference call to review the Company's financial and operating results on Thursday, April 25, 2024 at 8:00 a.m. Eastern Time.
  • Individuals wishing to participate in the conference call should dial toll-free (888) 660-6357, or (929) 201-6127 for international callers, and use conference ID number 9979064.
  • Marine Products Corporation is a leading manufacturer of high-quality fiberglass boats under the brand names Chaparral and Robalo.

iAnthus Announces Strategic Partnership with Timeless Vapes to Bring a Leading Lifestyle Brand to New Jersey

Retrieved on: 
Tuesday, April 2, 2024
Organization, The Company, Partnership, Patient, MPX, Cannabis, Timeless, Drug

NEW YORK and TORONTO, April 2, 2024 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCQB: ITHUF), a leading national cannabis consumer packaged goods company and owner of MPX-NJ dispensaries in New Jersey, announces a strategic partnership to bring Timeless Vapes ("Timeless"), a lifestyle brand leading the way in cannabis culture, to the New Jersey market.

Key Points: 
  • NEW YORK and TORONTO, April 2, 2024 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCQB: ITHUF), a leading national cannabis consumer packaged goods company and owner of MPX-NJ dispensaries in New Jersey, announces a strategic partnership to bring Timeless Vapes ("Timeless"), a lifestyle brand leading the way in cannabis culture, to the New Jersey market.
  • The launch of Timeless branded products are now available at all MPX-NJ dispensaries in New Jersey in Pennsauken, Gloucester Township, and Atlantic City.
  • Under this partnership, iAnthus and Timeless are working together to bring the full range of Timeless acclaimed products to New Jersey.
  • "We are eager to begin our journey in New Jersey alongside our esteemed partners at iAnthus," said Timeless Founder, Rocky Huang.

Timeless Vapes Enters New Jersey Cannabis Market

Retrieved on: 
Tuesday, April 2, 2024
Garden State, Organization, Partnership, Patient, MPX, Cannabis, Timeless, Drug

SCOTTSDALE, Ariz., April 2, 2024 /PRNewswire/ -- Timeless Vapes ("Timeless" or the "Company"), a lifestyle brand leading the way in cannabis culture, today announced its expansion into New Jersey in partnership with iAnthus Capital Holdings, Inc., a leading owner and operator of licensed cannabis cultivation, processing and dispensary facilities throughout the United States. iAnthus owns and operates three MPX-NJ dispensaries in New Jersey in Atlantic City, Gloucester Township and Pennsauken Township.

Key Points: 
  • iAnthus and Timeless are working together to continue expanding the Timeless brand on the East Coast.
  • New Jersey is the sixth U.S. market where Timeless operates, following Arizona, California, Missouri, Ohio and Oklahoma.
  • "Our partnership with Timeless Vapes emphasizes our commitment to providing consumers and patients with the highest quality cannabis products and brands," said Richard Proud, CEO of iAnthus.
  • "Timeless' mission to use cannabis as a tool to build community and enact positive change is exactly what the New Jersey market needs.

CrossFi Launches EVM Testnet in collaboration with CoinList to drive adoption of Non-Custodial Payment Solutions

Retrieved on: 
Tuesday, February 20, 2024
EVM, Ecosystem, MPX, SAN, Blockchain, Online shopping

SAN FRANCISCO, Feb. 20, 2024 /PRNewswire-PRWeb/ -- CrossFi, a next-generation digital ecosystem of cutting-edge payment solutions bridging the worlds of banking and blockchain, launches its EVM testnet in collaboration with CoinList. The testnet, scheduled to run for three months with $8.4M in MPX allocated for rewards across validators, developers and users, marks a significant milestone in CrossFi's path to mainnet and in realizing its mission to modernize the concepts of traditional finance through decentralized solutions. The main objectives for the testnet are to thoroughly test and validate the functionality, performance, and security of the CrossFi Chain network to ultimately enhance ecosystem development and community growth in the lead-up to mainnet.

Key Points: 
  • The CrossFi chain EVM testnet launch accelerates CrossFi's mission to provide secure and user-friendly, cross-border payments.
  • SAN FRANCISCO, Feb. 20, 2024 /PRNewswire-PRWeb/ -- CrossFi , a next-generation digital ecosystem of cutting-edge payment solutions bridging the worlds of banking and blockchain, launches its EVM testnet in collaboration with CoinList.
  • CrossFi Chain serves as the foundational pillar of the CrossFi ecosystem, boasting unparalleled scalability and cutting-edge capabilities.
  • With the ability to process up to 1 million transactions per second, CrossFi ensures lightning-fast transactions, making it ideal for high-volume and time-sensitive payment applications.

Pixelgen Technologies and Australian Biosearch Announce Distribution Agreement

Retrieved on: 
Tuesday, February 6, 2024
Partnership, Neoplasm, Knowledge, Immunotherapy, MPX, Research, Membrane, Therapy, 3D, Proteome, Medical research, Protein, Disease, Drug development, Health, Hematology, Cancer, Translation

STOCKHOLM and WANGARA, Australia, Feb. 6, 2024 /PRNewswire/ -- Pixelgen Technologies® announced today a non-exclusive agreement with leading distributor Australian Biosearch. The partnership will bring Pixelgen's Molecular Pixelation (MPX) kits for high-multiplex spatial analysis of membrane proteins to the Australian and New Zealand markets. 

Key Points: 
  • STOCKHOLM and WANGARA, Australia, Feb. 6, 2024 /PRNewswire/ -- Pixelgen Technologies ® announced today a non-exclusive agreement with leading distributor Australian Biosearch .
  • The partnership will bring Pixelgen's Molecular Pixelation (MPX) kits for high-multiplex spatial analysis of membrane proteins to the Australian and New Zealand markets.
  • "The Australasian biotech market is rapidly growing, and this agreement will help ensure our products reach this important region as we expand globally."
  • Earlier this month, Pixelgen announced a distribution agreement for Japan and launched a sales team in the U.S. with a new global sales position in Boston.

Pixelgen Technologies Signs Distribution Agreement in Japan

Retrieved on: 
Thursday, February 1, 2024
Medicine, Cell biology, MPX, Research, Immunotherapy, DNA, 3D, Proteome, COVID, University, Protein, Disease, Computational biology, NGS, Hematology, Health, Vaccine

STOCKHOLM and TOKYO, Feb. 1, 2024 /PRNewswire/ -- Pixelgen Technologies® announced today that it has signed a non-exclusive agreement with BioStream Co. Ltd of Japan to distribute its groundbreaking spatial proteomics tools for single cells. The agreement comes upon growing customer demand for Pixelgen's first product for spatial proteomics of single cells by next-generation sequencing, which launched last year.

Key Points: 
  • STOCKHOLM and TOKYO, Feb. 1, 2024 /PRNewswire/ -- Pixelgen Technologies ® announced today that it has signed a non-exclusive agreement with BioStream Co. Ltd of Japan to distribute its groundbreaking spatial proteomics tools for single cells.
  • The agreement comes upon growing customer demand for Pixelgen's first product for spatial proteomics of single cells by next-generation sequencing, which launched last year.
  • "We are extremely pleased to partner with BioStream, a world-class and well-established distributor in Japan," said Pixelgen Chief Commercial Officer Annika Branting.
  • "With growing demand for our first product, this distribution agreement marks an important first step toward establishing a strong global distribution network.

iAnthus Announces Strategic Partnership with Grön Edibles to Bring an Innovative Women Owned Edible Brand to New Jersey

Retrieved on: 
Tuesday, January 9, 2024
MPX, Culture, Partnership, OTCQB, Edible, Fair trade, Safety, CBN, Cannabis, THC, Growth, Drug

This collaboration marks a significant step in ensuring New Jersey consumers have access to the world’s most beautifully delicious edibles.

Key Points: 
  • This collaboration marks a significant step in ensuring New Jersey consumers have access to the world’s most beautifully delicious edibles.
  • The initial launch of Grön Sugar-Coated Pearl gummies is now available at all MPX-NJ locations and across dispensaries throughout New Jersey.
  • “This partnership with Grön represents a major milestone in our promise to bring the best cannabis experiences to our customers.
  • The partnership advances expansion plans for Grön in New Jersey and establishes a hub on the East Coast for the company’s future growth.

Marine Products Corporation Announces Date for Fourth Quarter 2023 Financial Results and Conference Call

Retrieved on: 
Tuesday, January 9, 2024
MPX, SURF, Chaparral, Common snook, Telephone, Interest

ATLANTA, Jan. 9, 2024 /PRNewswire/ -- Marine Products Corporation (NYSE: MPX) announced today that it will release its financial results for the fourth quarter ended December 31, 2023 on Thursday, January 25, 2024 before the market opens.  In conjunction with its earnings release, the Company will host a conference call to review the Company's financial and operating results on Thursday, January 25, 2024 at 8:00 a.m. Eastern Time.

Key Points: 
  • ATLANTA, Jan. 9, 2024 /PRNewswire/ -- Marine Products Corporation (NYSE: MPX) announced today that it will release its financial results for the fourth quarter ended December 31, 2023 on Thursday, January 25, 2024 before the market opens.
  • Individuals wishing to participate in the conference call should dial toll-free (888) 660-6357, or (929) 201-6127 for international callers, and use conference ID number 9979064.
  • Marine Products Corporation is a leading manufacturer of high-quality fiberglass boats under the brand names Chaparral and Robalo.
  • For information about Marine Products Corporation or this event, please contact:

Cannabis Workers in Atlantic City Choose UFCW Local 152 for a Voice

Retrieved on: 
Friday, January 5, 2024
Public Policy, Government, Natural Resources, Other Retail, State, Local, Tobacco, Labor, Cannabis, Retail, UFCW, The Botanist, MPX, Drug

Unionized workers at a cannabis dispensary in Atlantic City have voted to select United Food and Commercial Workers Local 152 as their representative in contract negotiations with their employer.

Key Points: 
  • Unionized workers at a cannabis dispensary in Atlantic City have voted to select United Food and Commercial Workers Local 152 as their representative in contract negotiations with their employer.
  • The 12 workers at the MPX NJ Atlantic City Medical Cannabis Dispensary join their fellow coworkers at MPX’s grow facility in Pleasantville, N.J., who joined UFCW Local 152 in 2023.
  • The new Local 152 members work as “budtenders” who provide knowledgeable customer service, facilitate retail sales and fulfill online orders.
  • “These workers have put their trust in our union to help improve their lives, and we will fight for what they deserve,” Local 152 President Brian String said.